Journal article
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation Analysis From COMBINE-AF
Abstract
BACKGROUND: Heart failure (HF) is common among patients with atrial fibrillation (AF), and accurate risk assessment is clinically important.
OBJECTIVES: The goal of this study was to investigate the incremental prognostic performance of N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T (hs-cTnT), and growth differentiation factor (GDF)-15 for HF risk stratification in patients with AF.
Authors
Haller PM; Jarolim P; Palazzolo MG; Bellavia A; Antman EM; Eikelboom J; Granger CB; Harrington J; Healey JS; Hijazi Z
Journal
Journal of the American College of Cardiology, Vol. 84, No. 16, pp. 1528–1540
Publisher
Elsevier
Publication Date
10 2024
DOI
10.1016/j.jacc.2024.07.023
ISSN
0735-1097